Pros and Cons of Allowing the Federal Government to Negotiate Prescription Drug Prices.

Outlines the arguments for and against allowing the Federal Government to negotiate prescription drug prices on behalf of Medicare beneficiaries, as expressly forbidden by the Medicare Prescription Drug, Improvement, and Modernization Act.

Bibliographic Details
Corporate Authors: Library of Congress. Congressional Research Service, ProQuest (Firm)
Format: eBook
Language:English
Published: [Place of publication not identified] : [publisher not identified], 2005.
Series:U.S. Congressional Research.
Subjects:
Online Access:Connect to the full text of this electronic book
Description
Summary:Outlines the arguments for and against allowing the Federal Government to negotiate prescription drug prices on behalf of Medicare beneficiaries, as expressly forbidden by the Medicare Prescription Drug, Improvement, and Modernization Act.
Item Description:Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
CRS Report.
Electronic resource.
Physical Description:1 online resource.